BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24444475)

  • 1. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol.
    Malki A; Laha R; Bergmeier SC
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
    Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, cytotoxic activity evaluation and HQSAR study of novel isosteviol derivatives as potential anticancer agents.
    Liu CJ; Yu SL; Liu YP; Dai XJ; Wu Y; Li RJ; Tao JC
    Eur J Med Chem; 2016 Jun; 115():26-40. PubMed ID: 26994841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
    Khaybullin RN; Liang X; Cisneros K; Qi X
    Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
    Wang TT; Liu Y; Chen L
    Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
    Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
    Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cytotoxic activity, and 2D- and 3D-QSAR studies of 19-carboxyl-modified novel isosteviol derivatives as potential anticancer agents.
    Liu CJ; Zhang T; Yu SL; Dai XJ; Wu Y; Tao JC
    Chem Biol Drug Des; 2017 Jun; 89(6):870-887. PubMed ID: 27878967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.
    Yang J; Liu Y; Xue C; Yu W; Zhang J; Qiao C
    Eur J Med Chem; 2014 Oct; 86():235-41. PubMed ID: 25164762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses, cytotoxic activity evaluation and HQSAR study of 1,2,3-triazole-linked isosteviol derivatives as potential anticancer agents.
    Liu CJ; Liu YP; Yu SL; Dai XJ; Zhang T; Tao JC
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5455-5461. PubMed ID: 27777008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective synthesis of 15- and 16-substituted isosteviol derivatives and their cytotoxic activities.
    Wu Y; Dai GF; Yang JH; Zhang YX; Zhu Y; Tao JC
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1818-21. PubMed ID: 19223180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
    Batista R; García PA; Castro MA; Miguel Del Corral JM; Speziali NL; de P Varotti F; de Paula RC; García-Fernández LF; Francesch A; San Feliciano A; de Oliveira AB
    Eur J Med Chem; 2013 Apr; 62():168-76. PubMed ID: 23353738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel quinuclidinone derivatives induce apoptosis in lung cancer via sphingomyelinase pathways.
    Malki A; Fathy L; El Ashry ES
    Drug Res (Stuttg); 2013 Jul; 63(7):362-9. PubMed ID: 23585304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A.
    Liu HC; Qiao LM; Zheng W; Xiang ZB; Chen HS; Yu SC; Zhang DZ; Wang T; Zhang YF; Jin YS
    Anticancer Agents Med Chem; 2020; 20(10):1241-1249. PubMed ID: 32116205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of novel oridonin analogues as potent anticancer agents.
    Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and apoptosis-inducing activities of steviol and isosteviol derivatives against human cancer cell lines.
    Ukiya M; Sawada S; Kikuchi T; Kushi Y; Fukatsu M; Akihisa T
    Chem Biodivers; 2013 Feb; 10(2):177-88. PubMed ID: 23418165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of isosteviol triazole conjugates for cancer therapy.
    Khaybullin RN; Zhang M; Fu J; Liang X; Li T; Katritzky AR; Okunieff P; Qi X
    Molecules; 2014 Nov; 19(11):18676-89. PubMed ID: 25405286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents.
    Luan T; Cao LH; Deng H; Shen QK; Tian YS; Quan ZS
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30598028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.
    Malki A; El-Sharkawy A; El Syaed M; Bergmeier S
    Anticancer Res; 2017 Apr; 37(4):1591-1601. PubMed ID: 28373419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.